|
References
| 1 |
Martin D. Abeloff. Clinical Oncology. Second Edition. 77-118.
back to
|
|
2
|
P. Winnard, Chang F,Rusckowski M,et al. Preparation and Use of NHS-MAG3 for Technetium-99m Labeling of DNA. Nuclear Medicine & Biology 1997; 24: 425-432.
back to
|
|
3
|
D.J. Hnatowich, P. Winnard Jr., F. Virzi, et al. Technetium-99m labeling of DNA oligonucleotides. J Nucl Med 1995; 36:2306-2314.
back to
|
|
4
|
Ma DD. Synthetic oligonucleotides as therapeutics: the coming of age. Biotechnol Annu Rev 2000; 5:155-96. (192 ref.)
back to
|
|
5
|
Cotter FE. Antisense oligonucleotides for haematological malignancies. Haematologica 1999 Jun; 84:19-22(10 ref.).
back to
|
|
6
|
Green DW, Roh H, Pippin J, et al. Antisense oligonucleotides: an evolving technology for the modulation of gene expression in human disease. J Am Coll Surg 2000 Jul; 191(1): 93-105(79ref.).
back to
|
|
7
|
Hnatowich DJ. Antisense and nuclear medicine. J Nucl Med 1999; 40:693-703.
back to
|
|
8
|
Lebedeva I, Benimetskaya L, Stein CA, et al. Cellular delivery of antisense oligonucleotides. Eur J Pharm Biopharm 2000 Jul; 50(1): 101-19 (255 ref.).
back to
|
|
9
|
David Piwnica-Worms. Making Sense Out of Anti-Sense: Challenges of Imaging Gene Translation with Radiolabeled Oliginucleotides. J Nucl Med 1994; 35:1064-1066.
back to
|
|
10
|
10 Persons DL. Quantitation of HER-2/neu and c-myc gene. Med Pathol 1997; 10:720-7.
back to
|
|
11
|
Salqia R. Molecular abnormalities in lung cancer. J Clin Oncol 1998; 16:1207-17.
back to
|
|
12
|
Seth A, Gupta S, Davis RJ. Cell cycle regulation of the c-myc transcriptional activation domain. Mol Cell Biol 1993; 13:4125-36.
back to
|
|
13
|
Gu W, Checova K,Tassi V, et al. Opposite regulation of gene transcription and cell proliferation by c-myc and MAX. Proc Natl Acad Sci USA 1993; 90:2935-39.
back to
|
|
14
|
Johnson JM, Carroll WL. c-myc hypermutation in Burkitt's lymphoma. Leuk Lymphoma 1992; 8:431-9.
back to
|
|
15
|
Dang CV. C-myc target genes involved in cell growth, apoptosis and metabolism. Mol Cell Biol 1999; 19:1.
back to
|
|
16
|
Park M, Vande Woude GF. Oncogene: genes associated with neuplastic diseases. In: Seriver CR, Beaudet AL, Sylws. Valle D, et al. The metabolic basis of inherited diseases. New York. Mc Graw Hill 1989:251-277.
back to
|
|
17
|
Dewanjee MK, Abdol KG,Kapadvanjwala M,et al. Noninvasive Imaging of c-myc Oncogene Messenger RNA with Indium-111-Antisense Probes in a Mammary Tumor-Bearing Mouse Model. J Nucl Med 1994; 35: 1054-1063.
back to
|
|
18
|
Scherr M, Rossi J.J., Sczakiel G., et al. RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts. Nucleic Acids Res 2000 Jul 1; 28(13): 2455-61.
back to
|
|
|
